日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Malignancy risk in patients with rheumatoid arthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a 5-year population-based cohort study

类风湿关节炎患者开始接受生物制剂或靶向合成疾病修饰抗风湿药物治疗后的恶性肿瘤风险:一项为期5年的基于人群的队列研究

Kao, Chung-Mao; Shih, Po-Cheng; Chen, Der-Yuan; Chen, Hsin-Hua

Quantitative assessment of rheumatoid arthritis treatment response using short-wave infrared hyperspectral imaging soft abundance scoring

利用短波红外高光谱成像软丰度评分对类风湿性关节炎治疗反应进行定量评估

Chen, Hsin-Hua; Wang, Hsin-Che; Lai, Kuo-Lung; Sung, Chiu-Chin; Chen, Jun-Peng; Fu, Yu-Wen; Weng, Shao-Jen; Chen, Hsian-Min

Author Correction: Crosstalk between FTH1 and PYCR1 dysregulates proline metabolism and mediates cell growth in KRAS-mutant pancreatic cancer cells

作者更正:FTH1 和 PYCR1 之间的相互作用会扰乱脯氨酸代谢并介导 KRAS 突变型胰腺癌细胞的生长。

Park, Ji Min; Su, Yen-Hao; Fan, Chi-Shuan; Chen, Hsin-Hua; Qiu, Yuan-Kai; Chen, Li-Li; Chen, Hsin-An; Ramasamy, Thamil Selvee; Chang, Jung-Su; Huang, Shih-Yi; Chang, Wun-Shaing Wayne; Lee, Alan Yueh-Luen; Huang, Tze-Sing; Kuo, Cheng-Chin; Chiu, Ching-Feng

Lenvatinib plus pembrolizumab compared to carboplatin plus paclitaxel for carboplatin and paclitaxel pretreated, recurrent, or advanced endometrial cancer

对于既往接受过卡铂和紫杉醇治疗的复发性或晚期子宫内膜癌,乐伐替尼联合帕博利珠单抗与卡铂联合紫杉醇的疗效比较

Wang, Shao-Jing; Sun, Lou; Shih, Yu-Hsiang; Lu, Ting-Fang; Chen, Yen-Fu; Hsu, Shih-Tien; Liu, Chin-Ku; Hwang, Sheau-Feng; Chen, Jem-Kun; Chen, Hsin-Hua; Lu, Chien-Hsing

Use of Sodium-Glucose Transport Protein 2 Inhibitors and the Incidence of Urolithiasis: A Multi-Database and Cross-Country Study in Patients With Type 2 Diabetes Mellitus

钠-葡萄糖协同转运蛋白2抑制剂的使用与2型糖尿病患者尿路结石发生率:一项多数据库跨国研究

Chung, Mu-Chi; Lin, Chia-Yen; Chang, Chao-Hsiang; Chang, Yi-Huei; Hsiao, Po-Jen; Lien, Chi-Shun; Wu, Laing-You; Wu, Ming-Ju; Shieh, Jeng-Jer; Hung, Peir-Haur; Chen, Hsin-Hua; Chung, Chi-Jung

Major adverse cardiovascular events or venous thromboembolism in patients with rheumatoid arthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a nationwide, population-based cohort study

类风湿关节炎患者开始接受生物制剂或靶向合成疾病修饰抗风湿药物治疗后发生主要不良心血管事件或静脉血栓栓塞的风险:一项全国性、基于人群的队列研究

Kao, Chung-Mao; Chen, Yen-Ju; Chen, Yi-Ming; Chen, Der-Yuan; Chen, Hsin-Hua

Mandatory Biological/Targeted Synthetic Disease-Modifying Antirheumatic Drugs Dose Reduction on Risk of Serious Infections in Patients with Rheumatoid Arthritis: A Nationwide Nested Case-Control Study

强制性生物/靶向合成疾病修饰抗风湿药物剂量减少对类风湿关节炎患者严重感染风险的影响:一项全国性嵌套病例对照研究

Chen, Der-Yuan; Lin, Ching-Heng; Chen, Hsin-Hua; Chen, Yi-Ming; Tang, Kuo-Tung

The effect of acupuncture on reducing postoperative complications in fracture patients: A retrospective analysis using the TriNetX database

针灸对降低骨折患者术后并发症的影响:基于TriNetX数据库的回顾性分析

Chang, Yi-Pin; Chen, Hsin-Hua; Tseng, Jui-Ju; Tsai, Chia-I

Clinical Response to Adalimumab Therapy and Its Determinants in Patients With Radiographic Axial Spondyloarthritis: A Prospective Real-World Study in Taiwan

阿达木单抗治疗对放射学轴性脊柱关节炎患者的临床反应及其决定因素:一项台湾前瞻性真实世界研究

Liu, Feng-Cheng; Lu, Cheng-Hsun; Kuo, Chang-Fu; Liao, Hsien-Tzung; Lee, Shinn-Shing; Su, Kuei-Ying; Sung, Wan-Yu; Tsai, Wen-Chan; Chen, Hsin-Hua; Chen, Hung-An; Wei, James Cheng-Chung; Tseng, Jui-Cheng; Weng, Meng-Yu; Chen, Hsiang-Cheng; Hsieh, Song-Chou

Evidence- and Consensus-Based Recommendations for the Screening, Diagnosis, and Management of Secondary Hypogammaglobulinemia in Patients With Systemic Autoimmune Rheumatic Diseases by the Taiwan College of Rheumatology Experts

台湾风湿病专家学会关于系统性自身免疫性风湿病患者继发性低丙种球蛋白血症的筛查、诊断和治疗的循证和共识性建议

Tsao, Yen-Po; Chen, Hsin-Hua; Hsieh, Tsu-Yi; Li, Ko-Jen; Yu, Kuang-Hui; Cheng, Tien-Tsai; Tseng, Jui-Cheng; Lu, Chun-Chi; Chen, Der-Yuan